NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

… the authorship of a journal article does not render it immune to criticism

Thank God pseudonymity of a hit piece under the guise of the Seeking Alpha short and distort scam banner, does somewhat offers that.

As Joshua Mitts wrote in his Short and Distort paper.

https://download.ssrn.com/20/02/19/ssrn_id3541328_code1806223.pdf

In this paper, I show how pseudonymity undermines reputational accountability in financial markets. I examine 2,900 attack articles against mid- and large-cap firms published on a website, Seeking Alpha, and show that pseudonymous ones are followed by stock-price declines and sharp reversals.

Thanks for the two contributions you misinterpret as analysis.

The first one I dissected, digested and spat out, so please spare us any nonsense of anyone wasting their time doing it again.

For any long with half a brain about due diligence, your hit piece was beneath amateurism.

Which is how pseudonymous short and distort hit pieces gets validated on Seeking Alpha in the first place.

I’ve seen quality pieces getting turned down, on idiotic grounds, simply because the “ticker” was in the short and distort target.

You wouldn’t want to publish stuff about a naked shorted company that actually contained positives.

I commend you on when your hit piece was published right in time to counter an upswing thus justifying market makers manipulation.

Welcome to the board by the way.

You are gonna fit right in 👍🏻